Joseph Oliveto
Chief Executive Officer at MILESTONE PHARMACEUTICALS INC.
Net worth: 449 730 $ as of 29/04/2024
Network origin in Joseph Oliveto first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 24 | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ.
15
| Subsidiary | Biotechnology | 15 |
| Subsidiary | Biotechnology | 13 | |
Pappas Capital LLC
 Pappas Capital LLC Investment ManagersFinance Pappas Capital LLC (Pappas Ventures) is a venture capital firm founded in 1994 by Art M. Pappas. The firm is headquartered in Durham, North Carolina.
10
| Private Company | Investment Managers | 10 |
Galleon Pharmaceuticals, Inc.
 Galleon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galleon Pharmaceuticals, Inc. develops and manufactures medicines for breathing-control conditions. Its product pipeline addresses the needs of both acute and chronic care patients. The firm's GAL-021 product is a small molecule for intravenous administration designed to support respiratory drive in surgical and critical care patients, and in particular those high risk patients with sleep apnea who are undergoing surgery. The company was founded by James C. Mannion in 2003 and is headquartered in Horsham, PA.
1
| Holding Company | Pharmaceuticals: Major | 1 |
Milestone Pharmaceuticals USA, Inc.
 Milestone Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Part of Milestone Pharmaceuticals, Inc., Milestone Pharmaceuticals USA, Inc. develops cardiovascular drugs. The company is based in Charlotte, NC. Joseph G. Oliveto has been the CEO of the company since 2017.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Joseph Oliveto via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Ballantyne Therapeutics, Inc.
 Ballantyne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ballantyne Therapeutics, Inc. manufactures pharmaceuticals. The private company is based in Charlotte, NC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Director of Finance/CFO | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Doctorate Degree Corporate Officer/Principal Masters Business Admin | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ATHENEXPAR | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Chief Executive Officer | |
| NOVARTIS AG | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Shearwater Corp.
 Shearwater Corp. Pharmaceuticals: MajorHealth Technology Part of Nektar Therapeutics, Shearwater Corp. is a company that provides research services focused on health care applications of advanced PEGylation. The company is based in Huntsville, AL. The company was founded by James R. Hudson, J. Milton Harris. Shearwater was acquired by Nektar Therapeutics on July 02, 2001 for $164.50 million. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| University of Montréal | College/University | Doctorate Degree Doctorate Degree | |
Council for Entrepreneurial Development
 Council for Entrepreneurial Development Miscellaneous Commercial ServicesCommercial Services Council for Entrepreneurial Development provides an interactive forum for entrepreneurs, investors, service professionals, academicians, researchers and public policy makers. Its services and programs include connections to capital, venture mentoring, and signature conferences empower member companies to go further. The company was founded in 1984 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| ONCOTELIC THERAPEUTICS, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| University of Wisconsin | College/University | Undergraduate Degree Graduate Degree | |
| Concordia University | College/University | Graduate Degree Undergraduate Degree | |
| DURATA THERAPEUTICS INC | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Operating Officer | |
| SANOFI | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| VIOQUEST PHARMACEUTICALS, INC. | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| The Royal College of Physicians | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Sales & Marketing | |
| The Pennsylvania State University | College/University | Undergraduate Degree Undergraduate Degree | |
| The University of North Carolina at Charlotte | College/University | Undergraduate Degree Undergraduate Degree | |
| Perelman School of Medicine | College/University | Doctorate Degree Corporate Officer/Principal | |
| The University of Waterloo | College/University | Undergraduate Degree Undergraduate Degree | |
| AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| University of Pennsylvania | College/University | Undergraduate Degree Corporate Officer/Principal | |
| Lundbeck USA Inc. | President Treasurer | ||
| CYMABAY THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chairman | |
Vicuron Pharmaceuticals LLC
 Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal President | |
| The University of Texas at Austin | College/University | Doctorate Degree Doctorate Degree | |
| McGill University | College/University | Undergraduate Degree Graduate Degree | |
Feldan Bio, Inc.
 Feldan Bio, Inc. Pharmaceuticals: MajorHealth Technology Feldan Bio, Inc. develops, produces and supplies recombinant proteins for therapeutic and research purposes. It specializes in cell culture products, cytokines, enzymes, receptors, clinical grade cytokines, and research proteins. The company was founded by Fran?ois-Thomas Michaud and Francois-Eric Lebeau in 2007 and is headquartered in Quebec, Canada. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Adolor Corp.
 Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | Biotechnology | Director/Board Member Director/Board Member | |
FoldRx Pharmaceuticals LLC
 FoldRx Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FoldRx Pharmaceuticals, Inc. provides drug discovery and clinical development services. It develops and discovers products focusing on first-in-class, disease-modifying, small molecule therapeutics to treat diseases of protein misfolding. The company was founded by Jeffery W. Kelly and Susan L. Lindquist in 2003 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Weill Cornell Medical College | College/University | Doctorate Degree Corporate Officer/Principal | |
| AVALO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | College/University | Undergraduate Degree Doctorate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Doctorate Degree | |
| VIA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Rectify Pharmaceuticals LLC
 Rectify Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Rectify Pharmaceuticals LLC is a biotech company that is developing positive functional modulators (PFMs) to address the underlying cause of serious ABC transporter-mediated diseases. The company is based in Cambridge, MA and was founded by Jonathan Moore. The company's team includes Xiaobing Li as Chief Development Officer, Robert Hughes as Executive Vice President of Drug Discovery and Preclinical Development, and Leif-Ann Tuohey as Senior Vice President and Head of Business Development. The company has received $100 million in Series A financing from Atlas Venture, Omega Funds, Forbion, and Longwood Fund. The CEO is Rajesh Devraj, who is also a venture partner at Atlas Venture. | Miscellaneous Commercial Services | Director/Board Member | |
Inversago Pharma, Inc.
 Inversago Pharma, Inc. Pharmaceuticals: MajorHealth Technology Inversago Pharma, Inc. develops novel gastrointestinal drugs. The company was founded by Fran?ois Ravenelle in and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Director/Board Member | |
Daiichi Sankyo, Inc.
 Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Graduate Degree |
Statistics
International
| United States | 41 |
| Canada | 7 |
| Switzerland | 2 |
| Sweden | 2 |
| France | 2 |
Sectoral
| Health Technology | 27 |
| Consumer Services | 18 |
| Commercial Services | 4 |
| Finance | 3 |
| Health Services | 2 |
Operational
| Director/Board Member | 254 |
| Corporate Officer/Principal | 153 |
| Independent Dir/Board Member | 77 |
| Chairman | 61 |
| Chief Executive Officer | 43 |
Most connected contacts
| Insiders | |
|---|---|
| Geoff Duyk | 42 |
| Georges Gemayel | 33 |
| Paul Edick | 27 |
| Nilesh Kumar | 26 |
| Yiu Nam Lau | 26 |
| William Keller | 26 |
| Michael Weiser | 26 |
| Guido Magni | 23 |
| Simon Pedder | 19 |
| Paul Truex | 17 |
| Curt Mikael von Euler-Chelpin | 17 |
| Seth Fischer | 17 |
| Richard Pasternak | 16 |
| Russell E. Kaufman | 16 |
| Staffan Schüberg | 15 |
- Stock Market
- Insiders
- Joseph Oliveto
- Company connections
